Open AccessMP14-18 NEOADJUVANT COMBINATION OF PAZOPANIB OR AXITINIB AND PD-1-ACTIVATED DC-CIK CELLS IMMUNOTHERAPY MAY FACILITATE SURGERY IN PATIENTS WITH RENAL CELL CARCINOMA
Author(s) -
Longbin Xiong,
Wu Zg,
Pei Dong,
Huiming Liu,
Ning Kang,
Yulu Peng,
Chunping Yu,
Yaqi Ding,
Desheng Weng,
Jianchuan Xia,
Lijuan Jiang,
Shengjie Guo,
Hui Han,
Fangjian Zhou,
Zhiling Zhang
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000001995.18
Subject(s) - pazopanib , axitinib , medicine , renal cell carcinoma , immunotherapy , oncology , cancer research , cancer , sunitinib